<unk><unk>  may prevent or delay the occurrence of<unk> , reduce the blood pressure, increase the efficacy of medications, decrease risk factors for<unk>  and reduce the incidence of target organ damage.<unk><unk>  should be implemented in all hypertensive patients irrespective of the hypertensive stage.<unk>  changes alone can be considered as initial antihypertensive measure in patients with stage 1<unk> , even in the presence of up to 1 or 2 risk factors (excluding diabetes or metabolic syndrome or established target organ damage). In these patients, pharmacologic therapy can wait for three to six months until<unk>  changes alone are provided a chance to control blood pressure.
Chronic hypertension lifestyle modification
Chronic stable angina treatment lipid management
Congestive heart failure lifestyle modification
Chronic stable angina treatment weight management
Chronic stable angina medical therapy
Chronic stable angina treatment diabetes control
Chronic stable angina treatment smoking cessation
Metabolic syndrome dietary therapy